Evidence map›Paper›PMID 34934448›Full record

ArticleExperimental and therapeutic medicine2022

Endoscopic assessment of sinonasal mucormycosis with SPIES: The 'battlefield' sign.

Viorel Zainea, Irina Gabriela Ionita, Silviu Pituru, Cătălina Pietroșanu, Andreea Rusescu, Cristian Dragos Stefanescu, Florentina Gherghiceanu, Florin Anghelina, Dragos Palade, Razvan Hainarosie

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Viorel ZaineaDepartment of ENT, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Irina Gabriela IonitaDepartment of ENT, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Silviu PituruDepartment of ENT, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Cătălina PietroșanuDepartment of ENT, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Andreea RusescuDepartment of ENT, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Cristian Dragos StefanescuDepartment of ENT, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Florentina GherghiceanuDepartment of ENT, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Florin AnghelinaDepartment of ENT, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Dragos PaladeDepartment of ENT, 'Grigore T. Popa' University of Medicine and Pharmacy, 700115 Iasi, Romania.
Razvan HainarosieDepartment of ENT, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Carol Davila University of Medicine and Pharmacy · ROGrigore T. Popa University of Medicine and Pharmacy · ROUniversity of Medicine and Pharmacy of Craiova · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sinonasal mucormycosis is an extremely challenging pathology for the ear, nose and throat (ENT) surgeon from a therapeutic point of view. The disease affects immunocompromised patients and exhibits lethal potential. Although the diagnosis is relatively easy to suspect due to the distinctive clinical aspects which consists of black crusting present in the nasal fossae able to be confirmed by biopsy, the treatment requires resection of all affected tissue with safety limits. Due to the tendency of invasion associated with this fungal infection and taking into account the location involved (the sinonasal area) and the grave condition of these patients, it is extremely important to perform only the minimal resection necessary, but that includes all tissue infected by the fungus. This article presents a minimally invasive method of evaluation that can be performed during endoscopic surgical intervention and that aids the surgeon to better evaluate the affected area. It is associated with no additional risks for the patients, but it helps the surgeon to perform the intervention efficiently while not damaging healthy tissue. The authors consider that the method presented will aid the surgeon during the endoscopic surgical intervention in evaluating the lesion and resecting all the affected tissue while preserving healthy areas.

Indexed as

endoscopic evaluationhealthy tissue resectionminimally invasivesinonasal mucormycosisSPIES endoscopy

Identifiers

PMID34934448
PMCPMC8652392
OpenAlexW3216055150

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.